The PROTECT Trial: PROpofol Titration to Enhance haemodynamiC sTability

NARecruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 2, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Anesthesia
Interventions
PROCEDURE

Propofol titration

Induction starts with propofol target-controlled Infusion (TCI) (Schnider model) at target effect-site drug concentration (Cet) 0.5-1.0 µg/mL and remifentanil TCI (Minto model) at Cet 0.5 ng/mL. If loss of consciousness (LOC) is not reached, propofol Cet is increased in 0.5-1.0 µg/mL steps. For intubation, remifentanil Cet increases up to 6.0 ng/mL.

PROCEDURE

Conventional propofol induction

Induction starts with propofol TCI at Cet 4-8 µg/mL and remifentanil TCI at Cet 2.5-3.5 ng/mL.

Trial Locations (4)

4031

RECRUITING

University Hospital Basel, Basel

4600

NOT_YET_RECRUITING

Kantonsspital Olten, soH, Olten

5404

NOT_YET_RECRUITING

Kantonsspital Baden, Baden

7000

NOT_YET_RECRUITING

Cantonal Hospital Graubünden, Chur

All Listed Sponsors
collaborator

University of Basel

OTHER

collaborator

University of Zurich

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT06980688 - The PROTECT Trial: PROpofol Titration to Enhance haemodynamiC sTability | Biotech Hunter | Biotech Hunter